The red eye: Diagnosis and treatment

American Family Physician

Volumn 54, Issue 8, 1996, Pages 2423-2430

  Hara, Jimmy H ^a  

^a KAISER PERMANENTE MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; BLEPHARITIS; CLINICAL EXAMINATION; CONJUNCTIVITIS; DRY EYE; EYE DISEASE; EYELID DISEASE; GENERAL PRACTICE; HUMAN; PAIN; PHOTOPHOBIA; VISUAL ACUITY;

CONJUNCTIVITIS; DIAGNOSIS, DIFFERENTIAL; DRAINAGE; EYE DISEASES; EYELID DISEASES; HUMANS; SUPPURATION;

EID: 0029730763     PISSN: 0002838X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (21)

1. American Academy of Ophthalmology. Managing the red eye [slide presentation]. San Francisco: American Academy of Ophthalmology, 1988.
2. Friedlaender MH. Immunologic aspects of diseases of the eye. JAMA 1992;268:2869-73.
3. Foster CS, Calonge M. Atopic keratoconjunctivitis. Ophthalmology 1990;97:992-1000.
4. Caldwell DR, Verin P, Hartwich-Young R, Meyer SM, Drake MM. Efficacy and safety of lodoxamide 0.1% vs cromolyn sodium 4% in patients with vernal keratoconjunctivitis. Am J Ophthalmol 1992; 113:632-7.
5. Titi MJ. A critical look at ocular allergy drugs. Am Fam Physician 1996;53:2637-42, 2645-6.
6. Abelson MB, George MA, Smith LM. Evaluation of 0.05% levocabastine versus 4% sodium cromolyn in the allergen challenge model. Ophthalmology 1995;102:310-6.
7. Tinkelman DG, Rupp G, Kaufman H, Pugely J, Schultz N. Double-masked, paired-comparison clinical study of ketorolac tromethamine 0.5% ophthalmic solution compared with placebo eyedrops in the treatment of seasonal allergic conjunctivitis. Surv Ophthalmol 1993;38(Suppl):133-40.
8. Riordan-Eva P, Vaughan DG. Eye. In: Tierney LM Jr, McPhee SJ, Papadakis MA, eds. Current medical diagnosis & treatment. 35th ed. Stamford, Conn.: Appleton & Lange, 1996:156-80.
9. Darougar S, Monnickendam MA, Woodland RM. Management and prevention of ocular viral and chlamydial infections. Crit Rev Microbiol 1989; 16:369-418.
10. Lemp MA. Recent developments in dry eye management. Ophthalmology 1987;94:1299-304.
11. Rubinfeld RS, Pfister RR, Stein RM, Foster CS, Martin NF, Stoleru S, et al. Serious complications of topical mitomycin-C after pterygium surgery. Ophthalmology 1992;99:1647-54.
12. Dart JK. Diseases and risks associated with contact lenses. Br J Ophthalmol 1993;77:49-53.
13. Matthews TD, Frazer DG, Minassian DC, Radford CF, Dart JK. Risks of keratitis and patterns of use with disposable contact lenses. Arch Ophthalmol 1992;110:1559-62.
14. Torok PG, Mader TH. Corneal abrasions: diagnosis and management. Am Fam Physician 1996;53:2521-9, 2532.
15. Mondino BJ. Inflammatory diseases of the peripheral cornea. Ophthalmology 1988;95:463-72.
16. Parks DJ, Abrams DA, Sarfarazi FA, Katz HR. Comparison of topical ciprofloxacin to conventional antibiotic therapy in the treatment of ulcerative keratitis. Am J Ophthalmol 1993;115:471-7.
17. Berger ST, Mondino BJ, Hoft RH, Donzis PB, Holland GN, Farley MK, et al. Successful medical management of Acanthamoeba keratitis. Am J Ophthalmol 1990;110:395-403.
18. Rosenbaum JT. An algorithm for the systemic evaluation of patients with uveitis: guidelines for the consultant. Semin Arthritis Rheum 1990;19: 248-57.
19. Fong LP, Sainz de la Maza M, Rice BA, Kupferman AE, Foster CS. Immunopathology of scleritis. Ophthalmology 1991;98:472-9.
20. O'Connor GR. Uveal tract and sciera. In: Vaughan D, Asbury T, Riordan-Eva P, eds. General ophthalmology. 13th ed. Norwalk, Conn.: Appleton & Lange, 1992:150-68.
21. Rosenberg LF. Glaucoma: early detection and therapy for prevention of vision loss. Am Fam Physician 1995;52:2289-98, 2303-4.